Partial change to stock option allotment recipients. Total remains 1,000 units, target shares remain 100,000. Number of recipients increased (204 to 211) without changing the total allotment. Allotment date: September 30.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9267","jir_company_name":"Genky DrugStores Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-09-25","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/9267-20260925-01.pdf","jir_short_summary":"Partial change to stock option allotment recipients. Total remains 1,000 units, target shares remain 100,000. Number of recipients increased (204 to 211) without changing the total allotment. Allotment date: September 30.","jir_summary":"### Summary of Change\nAt the meeting of the Board of Directors held today, it was resolved to increase the number of recipients to 211 by adding internal directors of the group companies as recipients, without changing the total number of stock acquisition rights. Recipients consist of internal directors excluding corporate auditors and directors and employees of our subsidiaries, and the number of stock acquisition rights to be allotted remains 1,000. There are no changes to the allotment date or other exercise conditions.\n\n### Impact and Outlook\nBy expanding the recipient base without changing the total and the number of target shares, employees may have more opportunities to exercise rights. Dilution is expected to be limited since the total number of stock acquisition rights remains unchanged. Depending on future exercise activity, it may impact capital structure, but as of now no new capital costs or issuance procedures changes have been disclosed.","jir_financial_highlights":"Total number of stock acquisition rights: 1,000 units (No change)\nNumber of recipients: 211 people (Increase)\nShares (number of target shares for stock acquisition rights): 100,000 shares (No change)\nAllotment date: September 30, 2026 (No change)","jir_category":"","jir_hashtags":"#GenkyStockOptionChange","jir_key_figures":"Total number of stock acquisition rights: 1,000 units (no change)\nNumber of recipients: 211 people (after change)\nAllotment date: September 30, 2026","jir_meta_title":"Genky Stock Options \u2013 Partial Change in Allotment Recipients | September 2026","jir_meta_description":"Genky changes the recipients for stock option allocations. Total remains 1,000 units; recipients increase to 211. Allotment date: September 30, 2026.","jir_og_title":"Genky \u2013 Partial Change in Stock Option Allotment Recipients","jir_og_description":"Genky selects additional recipients for stock option allotment; total remains unchanged. Key dates summarized.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9174,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-123314","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n